Autonomix Medical (AMIX) Income towards Parent Company (2022 - 2025)

Autonomix Medical (AMIX) has reported Income towards Parent Company for 4 consecutive years, with -$3.3 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Income towards Parent Company fell 20.24% year-over-year to -$3.3 million in Q4 2025; TTM through Dec 2025 was -$14.8 million, a 42.91% decrease from a year earlier, with the FY2025 full-year figure at -$9.0 million, up 26.04% from the prior year.
• Income towards Parent Company was -$3.3 million for Q4 2025 at Autonomix Medical, up from -$7.5 million in the prior quarter.
• Over five years, Income towards Parent Company peaked at -$544000.0 in Q4 2022 and troughed at -$7.5 million in Q3 2025.
• A 4-year average of -$2.8 million and a median of -$2.7 million in 2024 frame the typical range for Income towards Parent Company.
• Across the five-year window, Income towards Parent Company slumped 472.24% in 2023 and surged 63.35% in 2025, its largest moves.
• Over 4 years, Income towards Parent Company stood at -$544000.0 in 2022, then tumbled by 472.24% to -$3.1 million in 2023, then advanced by 12.88% to -$2.7 million in 2024, then fell by 20.24% to -$3.3 million in 2025.
• The last three Income towards Parent Company figures came in at -$3.3 million (Q4 2025), -$7.5 million (Q3 2025), and -$3.3 million (Q2 2025), per Business Quant data.